Release property study on the novel divalproex sodium enteric-coated capsules.

1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987. J Control Release (2014) 4.55

Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release (2000) 4.18

Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. J Affect Disord (2004) 1.02

Immune effects of extractives on bamboo biomass self-plasticization. Pak J Pharm Sci (2014) 1.02

Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteers. Epilepsy Res (2002) 1.01

Variability of macroscopic dimensions of Moso bamboo. Pak J Pharm Sci (2015) 0.96

Molecular bonding characteristics of Self-plasticized bamboo composites. Pak J Pharm Sci (2014) 0.94

Weibull statistical analysis of tensile strength of vascular bundle in inner layer of moso bamboo culm in molecular parasitology and vector biology. Pak J Pharm Sci (2014) 0.93

Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis. J Affect Disord (2009) 0.93

Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data. J Affect Disord (2005) 0.89

Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs. Int J Pharm (2002) 0.86

Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study. Eur Psychiatry (2009) 0.84

Once-daily dosing is appropriate for extended-release divalproex over a wide dose range, but not for enteric-coated, delayed-release divalproex: evidence via computer simulations and implications for epilepsy therapy. Epilepsy Res (2009) 0.83

Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate. Int J Pharm (2013) 0.82

Dissolution profile study on the novel doxycycline hydrochloride sustained-release capsules. Pak J Pharm Sci (2014) 0.78

Seizure control and side-effect profile after switching adult epileptic patients from standard to extended-release divalproex sodium. Clin Neurol Neurosurg (2009) 0.78

Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective disorder. Gen Hosp Psychiatry (2010) 0.78

Effects of divalproex sodium on hemoglobin level. Blood Cells Mol Dis (2009) 0.78

Study on novel galantaminehydrobromide sustained-release capsules and itsin vitro releasing property. Pak J Pharm Sci (2014) 0.77

Dissolution profile study on the novel doxycycline hydrochloride sustained-release capsules. Pak J Pharm Sci (2014) 0.78

Study on novel galantaminehydrobromide sustained-release capsules and itsin vitro releasing property. Pak J Pharm Sci (2014) 0.77